EUCODIS Bioscience Raises $2.76 million

EUCODIS Bioscience, a Vienna-based company providing customized enzymes to the pharmaceutical, chemical, and other industries, has received a cash injection of EUR 2 million ($2.76 million) from existing shareholders. That includes Pontis Capital, Wiener Wachstumsfonds, IBG, and ARAX.

4 February 2010•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail